Jeffrey Davis

Practice Areas

Jeff Davis advises healthcare organizations on Medicare and Medicaid billing and reimbursement issues, with a special focus on the federal 340B drug pricing program. He also counsels clients on emerging healthcare regulatory issues, including COVID-19 relief funding, surprise medical billing/No Surprises Act, and hospital price transparency, and provides strategic insights to clients on public policy matters under consideration by the U.S. Congress and federal agencies, such as drug pricing policy and nonprofit hospital issues.

Jeff is a frequent speaker on the 340B program for conferences and webinars organized by the American Health Law Association, the 340B Coalition, other national provider groups and state hospital associations.

Career

Jeff joined Bass, Berry & Sims in 2021. He previously was of counsel in the Health Law Practice group at Baker, Donelson, Bearman, Caldwell & Berkowitz, PC and co-led that firm’s Reimbursement Group. He spent more than seven years working as vice president and legislative and policy counsel for 340B Health, an association of more than 1,500 hospitals and health systems participating in the 340B program. Before his work at 340B Health, Jeff was the healthcare legislative assistant to U.S. Representative Shelley Berkley (D-NV).

Personal

JD, Boston University School of Law (2010)

BA, University of Maryland (2005) - magna cum laude

Professional Memberships

American Health Law Association (AHLA)

Awards